MoneyWorks4Me

Cadila Healthcare informs about press release

14 Feb 2022 Evaluate

Cadila Healthcare has informed that it enclosed a copy of press release dated February 14, 2022, titled ‘Zydus gets 180 day shared exclusivity for Roflumilast Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..